Position in BIOA
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$7,347,951
+$2,927,465 QoQ
Shares Held
420,123
+25.7% QoQ
Ownership
0.945%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2025
4 quarters on record
Voting authority
Sole 75.5421626523661.ToString("F0")%
Shared 0.ToString("F0")%
None 24.457837347633905.ToString("F0")%
Common Shares in BIOA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026JACOBS LEVY EQUITY MANAGEMENT, INC holds $198,176,624 across 13 Drug Manufacturers - Specialty & Generic names. BIOA ranks #6 (3.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
520,269 | $68,540,238 | |
| 2 | LNTH |
Lantheus Holdings, Inc.
|
577,645 | $43,814,373 | |
| 3 | ZTS |
Zoetis Inc.
|
304,877 | $36,039,510 | |
| 4 | IRWD |
Ironwood Pharmaceuticals Inc
|
3,632,477 | $12,749,994 | |
| 5 | BCRX |
Biocryst Pharmaceuticals Inc
|
1,004,373 | $9,561,630 | |
| 6 | BIOA |
BioAge Labs, Inc.
This page
|
420,123 | $7,347,951 | |
| 7 | PAHC |
Phibro Animal Health Corp
|
114,018 | $6,306,335 | |
| 8 | PCRX |
Pacira BioSciences, Inc.
|
188,186 | $4,253,003 |
All Filings in BIOA
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $7,347,951 | 420,123 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $4,420,486 | 334,126 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $1,252,957 | 213,088 | Shares | Sole | 2025-11-17 | |
| 2025-06-30 | $1,129,356 | 273,452 | Shares | Sole | 2025-08-14 | |
| No filing history on record for this holder in this stock. | ||||||